Broker Forecast - Barclays Capital issues a broker note on AstraZeneca PLC

Fri, 13th Sep 2019

Barclays Capital today reaffirms its overweight investment rating on AstraZeneca PLC (LON:AZN) and raised its price target to 8200p (from 8000p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk

FTSE 100 Latest
Value7,212.49
Change48.85